Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pradeep Tyagi is active.

Publication


Featured researches published by Pradeep Tyagi.


BJUI | 2012

Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey

Varant Kupelian; Raymond C. Rosen; Claus G. Roehrborn; Pradeep Tyagi; Michael B. Chancellor; John B. McKinlay

Study Type – Aetiology (cohort)


Luts: Lower Urinary Tract Symptoms | 2011

Promise of Urinary Nerve Growth Factor for Assessment of Overactive Bladder Syndrome

Hann-Chorng Kuo; Hsin-Tzu Liu; Zhonghong Guan; Pradeep Tyagi; Michael B. Chancellor

Overactive bladder syndrome (OAB) is highly prevalent bladder disorder in men and women. About 10–15% of the population suffers from urgency frequency with or without urgency urinary incontinence. It is estimated that 50–75% of patients with OAB may have urodynamic detrusor overactivity (DO). Urodynamic study invasive and most of the OAB patients might not accept it as a routine assessment. Therefore, a more objective and non‐invasive test for diagnosis and assessing DO from OAB patients is needed. Recently, urinary nerve growth factor (NGF) has gained great interest in detecting DO in patients with OAB. Urinary NGF level was found to increase in OAB and urodynamic DO. Urinary NGF levels correlated with severity of OAB symptoms. Patients with either idiopathic or neurogenic DO may have increased urinary NGF levels. Urinary NGF levels have been shown to decrease in patients with patients with OAB and DO who have been well treated with antimuscarinics or botulinum toxin injection, but not in those with persistent OAB after treatment. Not all patients with OAB can have an elevated urinary NGF level; it may also be increased in patients with interstitial cystitis/painful bladder syndrome and other lower urinary tract diseases, suggesting urinary NGF expression could be a product of bladder inflammation and a limited specificity of urinary NGF for diagnosing DO. The source of urinary NGF has not yet been fully explored yet. Nevertheless, urinary NGF level is likely to be a promising biomarker for diagnosis of DO from OAB patients, to monitor therapeutic outcome and predict disease progression.


Journal of Quality in Maintenance Engineering | 1997

Cost‐benefit analysis of a two‐unit standby system with post‐repair, activation time and correlated failures and repairs

Rakesh Gupta; Vikas Tyagi; Pradeep Tyagi

Presents the analysis of a two‐unit cold standby system in which the standby unit takes a random amount of time for operation whenever the operative unit fails. Each unit is first repaired by the assistant repairman and is then taken up for post‐repair if necessary. The failure and repair times of each unit are assumed to be correlated and their joint density is taken as bivariate exponential. Uses regenerative point technique to obtain various reliability characteristics of interest. Studies the behaviour of steady‐state availability through graphs. Verifies earlier results.


Archive | 2004

Use of lipid and hydrogel vehicles for treatment and drug delivery

Pradeep Tyagi; Michael B. Chancellor; Zhenhua Li; Yao-Chi Chuang; Groat William C. De; Naoki Yoshimura; Matthew O. Fraser; Leaf Huang


Archive | 2006

Active agent and formulations to minimize or alleviate bladder urgency and irritation and/or to enhance sexual function

Michael B. Chancellor; Pradeep Tyagi; Jonathan Kaufman


Archive | 2007

Drug delivery and intravesical instillation

Pradeep Tyagi; Michael B. Chancellor


Archive | 2014

UpregulationofAndrogen-ResponsiveGenesand TransformingGrowthFactor-b1CascadeGenesinaRat Modelof Non-Bacterial Prostatic Inflammation

Yasuhito Funahashi; Naoki Kawamorita; Pradeep Tyagi; Donald B. DeFranco; Ryosuke Takahashi; Momokazu Gotoh; Zhou Wang; Naoki Yoshimura


Archive | 2014

Infections/Inflammation of the Genitourinary Tract: Interstitial Cystitis

Naoki Kawamorita; Satoru Yoshikawa; Yoichi Arai; Pradeep Tyagi; Michael B. Chancellor; Naoki Yoshimura


ics.org | 2010

Liposome Platform for Intravesical Sequence-Specific Gene-Silencing Of NGF In Bladder

Pradeep Tyagi; Vikas Tyagi; Yoshio Sugino; Naoki Yoshimura; Jonathan Kaufmann; Michael B. Chancellor


ics.org | 2010

Intravesical Immune Suppression By Liposomal Tacrolimus In Cyclophosphamide Induced Overactive Bladder

Yao Chi Chuang; Pradeep Tyagi; Chao cheng Huang; Naoki Yoshimura; Moya Wu; Jonathan Kaufmann; Michael B. Chancellor

Collaboration


Dive into the Pradeep Tyagi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Claus G. Roehrborn

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Dae K. Kim

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge